Jin-Yi Xiang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jin-Yi Xiang has a total of 55 co-authors. Here are the top co-authors by number of shared publications:
- Lian-Ming Wu
Department of Radiology, School of Medicine, Ren Ji Hospital, Shanghai Jiao Tong University, Shanghai, China
12 shared publications Jun Pu
Department of Cardiology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China
8 shared publicationsDong-Aolei An
Department of Radiology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China
4 shared publications- Bing-Hua Chen
Department of Radiology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China
3 shared publications Guo-Jun Zhu
Department of Radiology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University School of Medicine, No.160 PuJian Rd, Shanghai 200127, China
3 shared publicationsJin-Yu Zheng
Department of Radiology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China
3 shared publications
Latest Publications
- 1 October 2026
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 321 (1)
Cross-Cohort Harmonization of Quantitative MRI Metrics: Considerations for Reference Value Generalizability
- 1 October 2026
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 321 (1)
Cross-Cohort Harmonization of Quantitative MRI Metrics: Considerations for Reference Value Generalizability
- Open Access
- 27 August 2026
- Published by Springer Nature in Insights into Imaging
- Vol. 17 (1) , 212
A contrast-enhanced CMR-based risk score integrating microvascular obstruction and intramyocardial hemorrhage extent for prognostic evaluation
Objectives: This study aims to compare the prognostic value of the extent of microvascular obstruction (MVO) combined with intramyocardial hemorrhage (IMH) for major adverse cardiovascular events (MACE) in patients with STEMI. Materials and methods: We analyzed 568 STEMI patients in this retrospective multicenter study. Microvascular injury was visualized using late gadolinium enhancement for MVO, and T2* mapping and T2-weighted cardiovascular magnetic resonance imaging for IMH. The Youden index was used as the cutoff value to divide the study population into four groups. The Eitel CMR risk score, Glasgow CMR risk score, and GRACE (Global Registry of Acute Coronary Events) score were used as references to form Scores 1 and 2. Score 3 included LVEF ≤ 45%, MVO > 1.06% LV, IMH > 0.47% LV, and the GRACE score. Results: During a median follow-up of 3.1 years (IQR: 1.7–5.0 years), 108 patients (19%) experienced MACE. Event rates increased stepwise across groups (8.8% to 58.3%). The combination of MVO > 1.06% LV and IMH > 0.47% LV emerged as the strongest predictor of MACE (HR: 9.646, 95% CI: 6.327–14.705 [ p < 0.001]). Score 3 (integrating GRACE score, LVEF, and quantitative MVO and IMH) demonstrated improved predictive performance for MACE compared to the GRACE score (AUC: 0.748), Score 1 (AUC: 0.825), and Score 2 (AUC: 0.802), achieving an AUC of 0.853. Conclusion: Our approach integrates quantitative information on MVO and IMH into a risk score that shows better prognostic value than established risk scores. Key Points: Question Current prognostic tools for ST-elevation myocardial infarction patients lack quantitative combined assessment of microvascular obstruction and intramyocardial hemorrhage, limiting precise risk stratification after reperfusion. Findings A novel cardiac magnetic resonance score integrating quantitative microvascular obstruction and intramyocardial hemorrhage extent achieved 0.853 area under the curve for major adverse cardiovascular events. Critical Relevance Statement This study develops a quantitative cardiac magnetic resonance risk score by integrating microvascular obstruction and intramyocardial hemorrhage, offering improved prognostic value for major adverse cardiovascular events in ST-elevation myocardial infarction patients over established clinical scores.
- 27 August 2026
- Published by Springer Nature in Insights into Imaging
- Vol. 17 (1) , 212
Open AccessA contrast-enhanced CMR-based risk score integrating microvascular obstruction and intramyocardial hemorrhage extent for prognostic evaluation
Objectives: This study aims to compare the prognostic value of the extent of microvascular obstruction (MVO) combined with intramyocardial hemorrhage (IMH) for major adverse cardiovascular events (MACE) in patients with STEMI. Materials and methods: We analyzed 568 STEMI patients in this retrospective multicenter study. Microvascular injury was visualized using late gadolinium enhancement for MVO, and T2* mapping and T2-weighted cardiovascular magnetic resonance imaging for IMH. The Youden index was used as the cutoff value to divide the study population into four groups. The Eitel CMR risk score, Glasgow CMR risk score, and GRACE (Global Registry of Acute Coronary Events) score were used as references to form Scores 1 and 2. Score 3 included LVEF ≤ 45%, MVO > 1.06% LV, IMH > 0.47% LV, and the GRACE score. Results: During a median follow-up of 3.1 years (IQR: 1.7–5.0 years), 108 patients (19%) experienced MACE. Event rates increased stepwise across groups (8.8% to 58.3%). The combination of MVO > 1.06% LV and IMH > 0.47% LV emerged as the strongest predictor of MACE (HR: 9.646, 95% CI: 6.327–14.705 [ p < 0.001]). Score 3 (integrating GRACE score, LVEF, and quantitative MVO and IMH) demonstrated improved predictive performance for MACE compared to the GRACE score (AUC: 0.748), Score 1 (AUC: 0.825), and Score 2 (AUC: 0.802), achieving an AUC of 0.853. Conclusion: Our approach integrates quantitative information on MVO and IMH into a risk score that shows better prognostic value than established risk scores. Key Points: Question Current prognostic tools for ST-elevation myocardial infarction patients lack quantitative combined assessment of microvascular obstruction and intramyocardial hemorrhage, limiting precise risk stratification after reperfusion. Findings A novel cardiac magnetic resonance score integrating quantitative microvascular obstruction and intramyocardial hemorrhage extent achieved 0.853 area under the curve for major adverse cardiovascular events. Critical Relevance Statement This study develops a quantitative cardiac magnetic resonance risk score by integrating microvascular obstruction and intramyocardial hemorrhage, offering improved prognostic value for major adverse cardiovascular events in ST-elevation myocardial infarction patients over established clinical scores.
- 1 August 2026
- Published by Radiological Society of North America (RSNA) in Radiology: Cardiothoracic Imaging
- Vol. 8 (4)
Prognostic Value of Cardiac MRI–derived Left-to-Right Global Longitudinal Strain Ratio in ST-Elevation Myocardial Infarction
A higher left-to-right ventricular global longitudinal strain ratio was independently associated with increased risk of all-cause mortality in the isolated left ventricular myocardial infarction cohort.
- 1 August 2026
- Published by Radiological Society of North America (RSNA) in Radiology: Cardiothoracic Imaging
- Vol. 8 (4)
Prognostic Value of Cardiac MRI–derived Left-to-Right Global Longitudinal Strain Ratio in ST-Elevation Myocardial Infarction
A higher left-to-right ventricular global longitudinal strain ratio was independently associated with increased risk of all-cause mortality in the isolated left ventricular myocardial infarction cohort.
- 1 June 2026
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 319 (3) , e252250
AI-based Histologic Heterogeneity of Microvascular Obstruction at Cardiac MRI for Predicting MACEs: A Multicenter Study
An artificial intelligence–based radiomic framework enabled automated microvascular obstruction segmentation and decoded the heterogeneity of severe microvascular injury, which was an independent predictor of major adverse cardiovascular events and improved risk stratification.
- 1 June 2026
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 319 (3) , e252250
AI-based Histologic Heterogeneity of Microvascular Obstruction at Cardiac MRI for Predicting MACEs: A Multicenter Study
An artificial intelligence–based radiomic framework enabled automated microvascular obstruction segmentation and decoded the heterogeneity of severe microvascular injury, which was an independent predictor of major adverse cardiovascular events and improved risk stratification.
- 22 May 2026
- Published by Oxford University Press (OUP) in European Heart Journal - Cardiovascular Imaging
Rethinking post-infarction remodelling: identification and validation of data-driven cardiac MRI phenotypes for risk stratification
Aims: Conventional definitions of adverse left ventricular remodelling (ALVR) following ST-elevation myocardial infarction (STEMI), which are based on longitudinal changes in left ventricular end-diastolic volume index and ejection fraction, have demonstrated limited prognostic value. This study aimed to identify prognostic relevant remodelling phenotypes using a data-driven approach on longitudinal cardiac magnetic resonance (CMR) data. Methods and results: In this prospective longitudinal study, a derivation cohort (n = 337) and an independent validation cohort (n = 190) of patients with reperfused STEMI were analysed. Patients underwent CMR at <7 days and 6-month follow-up. An unsupervised clustering algorithm was applied using baseline biventricular, biatrial, and infarct parameters, plus their longitudinal changes. Major adverse cardiovascular events (MACE) included all-cause mortality, recurrent myocardial infarction (MI), and heart failure. Three reproducible post-MI phenotypes were identified: Low Risk (n = 175), Early Remodelling (n = 96, severe acute injury with minimal longitudinal change), and Atrial-dominant Remodelling (n = 66, bi-atrial and ventricular enlargement). Phenotype-stratified MACE-free survival differed significantly in both cohorts (derivation P < 0.001; validation P = 0.002). In the validation cohort, both Early Remodelling (hazard ratio [HR] 4.73; 95% confidence interval [CI]: 1.77–12.64) and Atrial-dominant Remodelling (HR 4.02; 95% CI: 1.49–10.88) were associated with elevated MACE risk vs. the Low-Risk group; the Atrial-dominant Phenotype was further associated with heart failure hospitalization (subdistribution HR: 5.92; 95% CI: 1.04–33.56). Adding the derived phenotypes to baseline CMR parameters improved MACE discrimination (C-index 0.755 vs. 0.714; ΔC 0.041, 95% CI: 0.006–0.074), whereas conventional ALVR did not. Conclusion: Three reproducible post-MI remodelling phenotypes were identified, which provide superior risk stratification for MACE over conventional ALVR criteria and insights into post-MI heart failure.
- 22 May 2026
- Published by Oxford University Press (OUP) in European Heart Journal - Cardiovascular Imaging
Rethinking post-infarction remodelling: identification and validation of data-driven cardiac MRI phenotypes for risk stratification
Aims: Conventional definitions of adverse left ventricular remodelling (ALVR) following ST-elevation myocardial infarction (STEMI), which are based on longitudinal changes in left ventricular end-diastolic volume index and ejection fraction, have demonstrated limited prognostic value. This study aimed to identify prognostic relevant remodelling phenotypes using a data-driven approach on longitudinal cardiac magnetic resonance (CMR) data. Methods and results: In this prospective longitudinal study, a derivation cohort (n = 337) and an independent validation cohort (n = 190) of patients with reperfused STEMI were analysed. Patients underwent CMR at <7 days and 6-month follow-up. An unsupervised clustering algorithm was applied using baseline biventricular, biatrial, and infarct parameters, plus their longitudinal changes. Major adverse cardiovascular events (MACE) included all-cause mortality, recurrent myocardial infarction (MI), and heart failure. Three reproducible post-MI phenotypes were identified: Low Risk (n = 175), Early Remodelling (n = 96, severe acute injury with minimal longitudinal change), and Atrial-dominant Remodelling (n = 66, bi-atrial and ventricular enlargement). Phenotype-stratified MACE-free survival differed significantly in both cohorts (derivation P < 0.001; validation P = 0.002). In the validation cohort, both Early Remodelling (hazard ratio [HR] 4.73; 95% confidence interval [CI]: 1.77–12.64) and Atrial-dominant Remodelling (HR 4.02; 95% CI: 1.49–10.88) were associated with elevated MACE risk vs. the Low-Risk group; the Atrial-dominant Phenotype was further associated with heart failure hospitalization (subdistribution HR: 5.92; 95% CI: 1.04–33.56). Adding the derived phenotypes to baseline CMR parameters improved MACE discrimination (C-index 0.755 vs. 0.714; ΔC 0.041, 95% CI: 0.006–0.074), whereas conventional ALVR did not. Conclusion: Three reproducible post-MI remodelling phenotypes were identified, which provide superior risk stratification for MACE over conventional ALVR criteria and insights into post-MI heart failure.
- 21 April 2026
- Published by Oxford University Press (OUP) in European Heart Journal - Cardiovascular Imaging
- Vol. 27 (7) , 1368-1379
Splenic tissue alterations in ST-elevation myocardial infarction: determinants and prognostic implications
Aims: While previous studies suggest a cardio-splenic axis involving splenic activation and systemic inflammation, presence and clinical significance of splenic tissue alterations on cardiac magnetic resonance (CMR) in ST-segment–elevation myocardial infarction (STEMI) remain unclear. This study aims to identify determinants of splenic T1 patterns in STEMI and explore their association with adverse outcomes. Methods and results: This retrospective study enrolled STEMI patients undergoing CMR within 10 days after primary percutaneous coronary intervention (April 2017–October 2024). CMR evaluated infarction patterns, myocardial function, native splenic T1 times and extracellular volume (ECV). Major adverse cardiovascular events (MACE) included cardiovascular death, heart failure and myocardial re-infarction. Results were validated in a separate cohort. Associations between variables and outcomes were evaluated using Cox regression. The development and validation cohorts comprised 1037 (median age 60; 872 men) and 252 (median age 59; 212 men) patients, respectively. Over a median follow-up of 38 and 30 months, 207 and 40 MACE occurred. In multivariable Cox regression, both elevated splenic T1 z-score [adjusted hazard ratio (HR) 1.58] and splenic ECV (adjusted HR 1.22) independently predicted MACE, driven primarily by heart failure and non-target vessel re-infarction. The model combining clinical and conventional myocardial imaging risk factors with splenic T1 z-score demonstrated best discrimination among all tested models (development C index = 0.87; validation C index = 0.85). Conclusion: Elevated splenic T1 z-score and ECV assessed by CMR after STEMI independently predicted MACE, mainly because of higher risk of heart failure and non-target vessel re-infarction, providing incremental prognostic value over traditional clinical and imaging risk markers.
- 21 April 2026
- Published by Oxford University Press (OUP) in European Heart Journal - Cardiovascular Imaging
- Vol. 27 (7) , 1368-1379
Splenic tissue alterations in ST-elevation myocardial infarction: determinants and prognostic implications
Aims: While previous studies suggest a cardio-splenic axis involving splenic activation and systemic inflammation, presence and clinical significance of splenic tissue alterations on cardiac magnetic resonance (CMR) in ST-segment–elevation myocardial infarction (STEMI) remain unclear. This study aims to identify determinants of splenic T1 patterns in STEMI and explore their association with adverse outcomes. Methods and results: This retrospective study enrolled STEMI patients undergoing CMR within 10 days after primary percutaneous coronary intervention (April 2017–October 2024). CMR evaluated infarction patterns, myocardial function, native splenic T1 times and extracellular volume (ECV). Major adverse cardiovascular events (MACE) included cardiovascular death, heart failure and myocardial re-infarction. Results were validated in a separate cohort. Associations between variables and outcomes were evaluated using Cox regression. The development and validation cohorts comprised 1037 (median age 60; 872 men) and 252 (median age 59; 212 men) patients, respectively. Over a median follow-up of 38 and 30 months, 207 and 40 MACE occurred. In multivariable Cox regression, both elevated splenic T1 z-score [adjusted hazard ratio (HR) 1.58] and splenic ECV (adjusted HR 1.22) independently predicted MACE, driven primarily by heart failure and non-target vessel re-infarction. The model combining clinical and conventional myocardial imaging risk factors with splenic T1 z-score demonstrated best discrimination among all tested models (development C index = 0.87; validation C index = 0.85). Conclusion: Elevated splenic T1 z-score and ECV assessed by CMR after STEMI independently predicted MACE, mainly because of higher risk of heart failure and non-target vessel re-infarction, providing incremental prognostic value over traditional clinical and imaging risk markers.
- 19 December 2025
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 47 (8) , 988-989
CMR phenotyping in sarcoidosis: a leap forward, but is simplicity the ultimate sophistication?
- 19 December 2025
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 47 (8) , 988-989
CMR phenotyping in sarcoidosis: a leap forward, but is simplicity the ultimate sophistication?
- Open Access
- 18 December 2025
- Published by MDPI AG in Diagnostics
- Vol. 15 (24) , 3240
Pericardial Fat Radiomics to Predict Left Ventricular Involvement and Provide Incremental Prognostic Value in ARVC
Background/Objectives: To explore the predictive value of pericardial fat tissue (PFT) radiomics for left ventricular (LV) involvement and major adverse cardiac events (MACE) in arrhythmogenic right ventricular cardiomyopathy (ARVC). Methods: In this retrospective multicenter study, LV involvement was assessed using cardiac magnetic resonance (CMR). A radiomic score (RS) derived from PFT was developed to predict LV involvement. The predictive accuracy of the RS was evaluated through receiver operating characteristic (ROC) analysis. Additionally, multivariable Cox regression analysis was employed to assess the prognosis across the entire dataset. Kaplan–Meier survival curves were used to evaluate the association between RS and MACE. Results: A total of 122 patients (mean age, 44 years ± 17; 76 male) were included, 90 for a development set and 32 for an external test set. The RS demonstrated good predictive performance for LV involvement in both the development and external test sets, with area under the curve (AUC) values of 0.771 and 0.785, respectively. Moreover, a high RS (≥−0.38) was independently associated with MACE during a median follow-up of 5 years (hazard ratio, 3.452; p < 0.001). Based on the right ventricular ejection fraction (RVEF) and RS, a simplified risk score was developed to categorize patients into three groups: high-risk (RVEF ≤ 40%, RS ≥ −0.38), intermediate-risk (RVEF ≤ 40%, RS < −0.38 or RVEF > 40%, RS ≥ −0.38), and low-risk (RVEF > 40%, RS < −0.38). Conclusions: The PFT radiomics can predict LV involvement and be associated with MACE in ARVC patients.
- 18 December 2025
- Published by MDPI AG in Diagnostics
- Vol. 15 (24) , 3240
Open AccessPericardial Fat Radiomics to Predict Left Ventricular Involvement and Provide Incremental Prognostic Value in ARVC
Background/Objectives: To explore the predictive value of pericardial fat tissue (PFT) radiomics for left ventricular (LV) involvement and major adverse cardiac events (MACE) in arrhythmogenic right ventricular cardiomyopathy (ARVC). Methods: In this retrospective multicenter study, LV involvement was assessed using cardiac magnetic resonance (CMR). A radiomic score (RS) derived from PFT was developed to predict LV involvement. The predictive accuracy of the RS was evaluated through receiver operating characteristic (ROC) analysis. Additionally, multivariable Cox regression analysis was employed to assess the prognosis across the entire dataset. Kaplan–Meier survival curves were used to evaluate the association between RS and MACE. Results: A total of 122 patients (mean age, 44 years ± 17; 76 male) were included, 90 for a development set and 32 for an external test set. The RS demonstrated good predictive performance for LV involvement in both the development and external test sets, with area under the curve (AUC) values of 0.771 and 0.785, respectively. Moreover, a high RS (≥−0.38) was independently associated with MACE during a median follow-up of 5 years (hazard ratio, 3.452; p < 0.001). Based on the right ventricular ejection fraction (RVEF) and RS, a simplified risk score was developed to categorize patients into three groups: high-risk (RVEF ≤ 40%, RS ≥ −0.38), intermediate-risk (RVEF ≤ 40%, RS < −0.38 or RVEF > 40%, RS ≥ −0.38), and low-risk (RVEF > 40%, RS < −0.38). Conclusions: The PFT radiomics can predict LV involvement and be associated with MACE in ARVC patients.
- 1 September 2025
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 316 (3) , e250078
Left Atrial Minimum Volume Index at Cardiac MRI Predicts Adverse Outcomes after Acute Myocardial Infarction
Left atrial minimum volume index at cardiac MRI had incremental prognostic value beyond traditional risk factors in predicting major adverse cardiovascular events among participants with acute myocardial infarction.
- 1 September 2025
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 316 (3) , e250078
Left Atrial Minimum Volume Index at Cardiac MRI Predicts Adverse Outcomes after Acute Myocardial Infarction
Left atrial minimum volume index at cardiac MRI had incremental prognostic value beyond traditional risk factors in predicting major adverse cardiovascular events among participants with acute myocardial infarction.
- 8 May 2025
- Published by Oxford University Press (OUP) in European Heart Journal - Cardiovascular Imaging
- Vol. 26 (8) , 1376-1386
Cardiac magnetic resonance-derived extracellular volume radiomics in reperfused ST-elevation myocardial infarction: long-term prognostic value and risk stratification
Aims: Global extracellular volume (ECV) fraction independently predicts outcomes after ST-elevation myocardial infarction (STEMI), but microvascular injuries complicate its interpretation. This study aims to assess the prognostic value of ECV-derived radiomics [radiomics score (RadScore)] from cardiac magnetic resonance (CMR) for risk stratification in reperfused STEMI patients. Methods and results: We retrospectively included 441 reperfused STEMI patients (mean age 60 ± 11 years; 371 males) from two centres, divided into development (n = 347) and validation cohort (n = 94) by centres. CMR scan was performed 1 week within the index event. ECV mapping was obtained from pre- and post-contrast T1 mappings. RadScore was developed through radiomics analysis on ECV mapping, and its predictive performance for major adverse cardiovascular events (MACE) was evaluated via logistic and Cox regression analyses. Over a median 3.1-year follow-up, MACE occurred in 81 patients (18.4%). RadScore showed strong predictive capability with an area under the curve (AUC) of 0.865 [95% confidence interval (CI): 0.768–0.962] and 0.821 (95% CI: 0.701–0.940) on the internal and external test cohort, respectively, reclassifying 44% and 32% of patients over clinical model, respectively. Patients with RadScore above the optimal threshold (RS+) experienced a more than 12-fold increase in MACE risk (95% CI: 2.96–47.71, P < 0.001) after adjusting for known risk factors. RS + provides incremental prognostic value beyond LVEF. Conclusion: RadScore derived from ECV mapping was able to predict MACE and provided incremental prognostic value beyond established risk factors. Our findings underscore the potential long-term impact of acute changes in extracellular space patterns after myocardial infarction.
- 8 May 2025
- Published by Oxford University Press (OUP) in European Heart Journal - Cardiovascular Imaging
- Vol. 26 (8) , 1376-1386
Cardiac magnetic resonance-derived extracellular volume radiomics in reperfused ST-elevation myocardial infarction: long-term prognostic value and risk stratification
Aims: Global extracellular volume (ECV) fraction independently predicts outcomes after ST-elevation myocardial infarction (STEMI), but microvascular injuries complicate its interpretation. This study aims to assess the prognostic value of ECV-derived radiomics [radiomics score (RadScore)] from cardiac magnetic resonance (CMR) for risk stratification in reperfused STEMI patients. Methods and results: We retrospectively included 441 reperfused STEMI patients (mean age 60 ± 11 years; 371 males) from two centres, divided into development (n = 347) and validation cohort (n = 94) by centres. CMR scan was performed 1 week within the index event. ECV mapping was obtained from pre- and post-contrast T1 mappings. RadScore was developed through radiomics analysis on ECV mapping, and its predictive performance for major adverse cardiovascular events (MACE) was evaluated via logistic and Cox regression analyses. Over a median 3.1-year follow-up, MACE occurred in 81 patients (18.4%). RadScore showed strong predictive capability with an area under the curve (AUC) of 0.865 [95% confidence interval (CI): 0.768–0.962] and 0.821 (95% CI: 0.701–0.940) on the internal and external test cohort, respectively, reclassifying 44% and 32% of patients over clinical model, respectively. Patients with RadScore above the optimal threshold (RS+) experienced a more than 12-fold increase in MACE risk (95% CI: 2.96–47.71, P < 0.001) after adjusting for known risk factors. RS + provides incremental prognostic value beyond LVEF. Conclusion: RadScore derived from ECV mapping was able to predict MACE and provided incremental prognostic value beyond established risk factors. Our findings underscore the potential long-term impact of acute changes in extracellular space patterns after myocardial infarction.